Malignant tumors of the minor salivary glands. Retrospective study on 59 cases
Med Oral. 2001 Mar-Apr;6(2):142-7.
[Article in
English,
Spanish]
Affiliation
- 1 Servicio de Cirugía Oral y Maxilofacial, Hospital Universitario Vall d'Hebron, Barcelona, España. gonzalez@gnation.com
Abstract
Minor salivary glands cancer account for 2-4% of head and neck cancer, 10% of all oral cavity cancer and 15-23% of all salivary glands cancer (1). There is a remarkable variation in clinical presentation, behavior and histology of those neoplasms. The incidence of malignancy is around 52-60% (2-4) Several classifications of salivary gland tumors have been presented, but for the present study we have utilized the WHO classification of 1992 (5). We present the results of a review of our experience with those malignancies, considering prognostic factors as histopathology, tumor grade, clinical staging, age and sex, primary location, regional and distant metastasis.
MeSH terms
-
Adenocarcinoma, Clear Cell / epidemiology
-
Adenocarcinoma, Clear Cell / pathology
-
Adolescent
-
Adult
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Carcinoma / epidemiology*
-
Carcinoma / pathology
-
Carcinoma / secondary
-
Carcinoma, Adenoid Cystic / epidemiology
-
Carcinoma, Adenoid Cystic / pathology
-
Carcinoma, Mucoepidermoid / epidemiology
-
Carcinoma, Mucoepidermoid / pathology
-
Female
-
Follow-Up Studies
-
Humans
-
Incidence
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Prognosis
-
Proportional Hazards Models
-
Retrospective Studies
-
Salivary Gland Neoplasms / epidemiology*
-
Salivary Gland Neoplasms / pathology
-
Salivary Glands, Minor / pathology*
-
Sex Factors
-
Spain / epidemiology
-
Statistics as Topic
-
Survival Analysis